These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 22133506)

  • 21. Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates.
    Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
    Exp Parasitol; 2008 Mar; 118(3):378-85. PubMed ID: 18053992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmodium falciparum multiple infections, disease severity and host characteristics in malaria affected travellers returning from Africa.
    Nicastri E; Paglia MG; Severini C; Ghirga P; Bevilacqua N; Narciso P
    Travel Med Infect Dis; 2008 Jul; 6(4):205-9. PubMed ID: 18571110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.
    Shi YP; Sayed U; Qari SH; Roberts JM; Udhayakumar V; Oloo AJ; Hawley WA; Kaslow DC; Nahlen BL; Lal AA
    Infect Immun; 1996 Jul; 64(7):2716-23. PubMed ID: 8698500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection.
    Dent AE; Moormann AM; Yohn CT; Kimmel RJ; Sumba PO; Vulule J; Long CA; Narum DL; Crabb BS; Kazura JW; Tisch DJ
    Malar J; 2012 Aug; 11():287. PubMed ID: 22909378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-terminal polymorphism of Plasmodium falciparium merozoite surface protein-1 (MSP-1) from Tak Province, Thailand.
    Viputtigul K; Tungpukdee N; Ruangareerate T; Luplertlop N; Wilairatana P; Gaywee J; Krudsood S
    Southeast Asian J Trop Med Public Health; 2013 Jan; 44(1):1-12. PubMed ID: 23682431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.
    Dent AE; Chelimo K; Sumba PO; Spring MD; Crabb BS; Moormann AM; Tisch DJ; Kazura JW
    Malar J; 2009 Jul; 8():162. PubMed ID: 19607717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus.
    King CL; Malhotra I; Wamachi A; Kioko J; Mungai P; Wahab SA; Koech D; Zimmerman P; Ouma J; Kazura JW
    J Immunol; 2002 Jan; 168(1):356-64. PubMed ID: 11751981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.
    Cavanagh DR; Dodoo D; Hviid L; Kurtzhals JA; Theander TG; Akanmori BD; Polley S; Conway DJ; Koram K; McBride JS
    Infect Immun; 2004 Nov; 72(11):6492-502. PubMed ID: 15501780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.
    Sutton PL; Clark EH; Silva C; Branch OH
    Malar J; 2010 Jan; 9():3. PubMed ID: 20047674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic diversity and genotype multiplicity of Plasmodium falciparum infections in symptomatic individuals in the maritime region of Togo.
    Awaga KL; Missihoun TD; Karou SD; Djadou KE; Chabi NW; Akati A; Lawson-Hukportie A; Amevo K; Djegno K; Guéant JL; Sanni A; Amouzou SK
    Trop Med Int Health; 2012 Feb; 17(2):153-60. PubMed ID: 22074288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy.
    Dent A; Malhotra I; Mungai P; Muchiri E; Crabb BS; Kazura JW; King CL
    J Immunol; 2006 Nov; 177(10):7139-45. PubMed ID: 17082631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India.
    Lucchi NW; Tongren JE; Jain V; Nagpal AC; Kauth CW; Woehlbier U; Bujard H; Dash AP; Singh N; Stiles JK; Udhayakumar V
    Malar J; 2008 Jul; 7():121. PubMed ID: 18601721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody specificities of children living in a malaria endemic area to inhibitory and blocking epitopes on MSP-1 19 of Plasmodium falciparum.
    Omosun YO; Adoro S; Anumudu CI; Odaibo AB; Uthiapibull C; Holder AA; Nwagwu M; Nwuba RI
    Acta Trop; 2009 Mar; 109(3):208-12. PubMed ID: 19081386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands.
    Badu K; Afrane YA; Larbi J; Stewart VA; Waitumbi J; Angov E; Ong'echa JM; Perkins DJ; Zhou G; Githeko A; Yan G
    BMC Infect Dis; 2012 Mar; 12():50. PubMed ID: 22380785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity.
    Bowman NM; Juliano JJ; Snider CJ; Kharabora O; Meshnick SR; Vulule J; John CC; Moormann AM
    Am J Trop Med Hyg; 2016 Sep; 95(3):580-7. PubMed ID: 27481054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.
    Keitel WA; Kester KE; Atmar RL; White AC; Bond NH; Holland CA; Krzych U; Palmer DR; Egan A; Diggs C; Ballou WR; Hall BF; Kaslow D
    Vaccine; 1999 Oct; 18(5-6):531-9. PubMed ID: 10519944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polymerase chain reaction/ligase detection reaction fluorescent microsphere assay to determine Plasmodium falciparum MSP-119 haplotypes.
    Dent AE; Yohn CT; Zimmerman PA; Vulule J; Kazura JW; Moormann AM
    Am J Trop Med Hyg; 2007 Aug; 77(2):250-5. PubMed ID: 17690395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope-specific impairment of production of antibody against merozoite surface glycoprotein 1 of Plasmodium falciparum in symptomatic patients with malaria.
    Fu J; Hato M; Ohmae H; Matsuoka H; Kawabata M; Tanabe K; Miyamoto Y; Leafasia JL; Chinzei Y; Ohta N
    Parasitol Res; 2000 May; 86(5):345-51. PubMed ID: 10836508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro.
    Egan AF; Burghaus P; Druilhe P; Holder AA; Riley EM
    Parasite Immunol; 1999 Mar; 21(3):133-9. PubMed ID: 10205793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human antibodies to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface protein 1 (MSP-1) exhibit a highly skewed, peptide-specific light chain distribution.
    Jouin H; Garraud O; Longacre S; Baleux F; Mercereau-Puijalon O; Milon G
    Immunol Cell Biol; 2005 Aug; 83(4):392-5. PubMed ID: 16033534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.